Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The company aims to do just that.

Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

As the industry looks to 2025, the health care and life sciences sectors are poised for growth, driven by groundbreaking ...

The single-cell and spatial biology company reported quarterly sales of $165.02 million, down 10% year over year, beating the consensus of $159.39 million. Gross margin was 67% for the fourth ...

Rogue Funds, an investment management company, released its fourth quarter 2024 investor letter. A copy of the letter can be ...

U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of about $30 billion, a person familiar with the matter said on Monday. The ...

Cyclopure, which has roots at Northwestern University's chemistry department, is moving out of its old digs in Lincoln Park.

Tiziana Life Sciences Ltd., a biotechnology company pioneering breakthrough immunomodulation therapies, has entered a ...

What considerations should developers in Denver-Boulder keep in mind when planning future life sciences facilities, particularly around the flexibility required for evolving technologies?

No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure TrialAchieve Reiterates Planned Cytisinicline NDA Submission in Q2 ...

10x Genomics posted a Q4 EPS loss of $(0.40), missing the $(0.30) estimate. The company’s 2025 sales guidance of $610M-$630M is below the $631.14M consensus. Get access to your new suite of high ...